We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | BOV:PFIZ34 | Bovespa | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.22 | -0.59% | 36.82 | 36.64 | 37.05 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 37.40 | 36.53 | 37.40 | 15,018 | 23:00:00 |
| Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
|---|---|---|---|---|---|---|
| 14 Mar 2025 | 36.82 | -0.22 | -0.59% | 36.53 | 37.40 | 15,018 |
| 13 Mar 2025 | 37.04 | -0.25 | -0.67% | 37.01 | 37.92 | 5,584 |
| 12 Mar 2025 | 37.29 | -0.59 | -1.56% | 37.15 | 38.15 | 5,459 |
| 11 Mar 2025 | 37.88 | -0.96 | -2.47% | 37.71 | 38.78 | 6,723 |
| 10 Mar 2025 | 38.84 | 0.36 | 0.94% | 38.35 | 39.40 | 3,433 |
| 07 Mar 2025 | 38.48 | 0.78 | 2.07% | 37.70 | 38.79 | 5,548 |
| 06 Mar 2025 | 37.70 | 0.57 | 1.54% | 36.98 | 38.05 | 8,294 |
| 05 Mar 2025 | 37.13 | -1.57 | -4.06% | 37.11 | 38.70 | 2,058 |
| 28 Feb 2025 | 38.70 | 0.90 | 2.38% | 37.90 | 38.70 | 2,544 |
| 27 Feb 2025 | 37.80 | -0.50 | -1.31% | 37.80 | 38.27 | 2,051 |
| 26 Feb 2025 | 38.30 | -0.19 | -0.49% | 38.09 | 38.88 | 1,695 |
| 25 Feb 2025 | 38.49 | 0.18 | 0.47% | 38.13 | 38.90 | 15,596 |
| 24 Feb 2025 | 38.31 | 0.41 | 1.08% | 37.01 | 38.45 | 6,097 |
| 21 Feb 2025 | 37.90 | 1.22 | 3.33% | 36.78 | 37.90 | 6,097 |
| 20 Feb 2025 | 36.68 | -0.25 | -0.68% | 36.68 | 37.26 | 7,917 |
| 19 Feb 2025 | 36.93 | 0.66 | 1.82% | 36.22 | 37.00 | 3,936 |
| 18 Feb 2025 | 36.27 | -0.35 | -0.96% | 36.20 | 36.74 | 5,715 |
| 17 Feb 2025 | 36.62 | 0.01 | 0.03% | 36.30 | 36.74 | 1,408 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
